Literature DB >> 11987822

Biology and pathogenesis of lymphocytic choriomeningitis virus infection.

M B A Oldstone1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11987822     DOI： 10.1007/978-3-642-56055-2_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  94 in total

1.  Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P.

Authors:  Winfried R Beyer; Dennis Pöpplau; Wolfgang Garten; Dorothee von Laer; Oliver Lenz
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity.

Authors:  A Grande-Pérez; S Sierra; M G Castro; E Domingo; P R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-05       Impact factor: 11.205

3.  An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells.

Authors:  Andrew Stamm; Laura Valentine; Rashaun Potts; Mary Premenko-Lanier
Journal:  Virology       Date:  2012-02-04       Impact factor: 3.616

4.  The Anatomy of a Career in Science.

Authors:  Michael B A Oldstone
Journal:  DNA Cell Biol       Date:  2016-02-02       Impact factor: 3.311

5.  Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.

Authors:  Christelle Pythoud; Sylvia Rothenberger; Luis Martínez-Sobrido; Juan Carlos de la Torre; Stefan Kunz
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

Review 6.  Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response.

Authors:  Michael B A Oldstone; Kevin P Campbell
Journal:  Virology       Date:  2010-12-23       Impact factor: 3.616

7.  Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus.

Authors:  Stefan Kunz; Jillian M Rojek; Amanda J Roberts; Dorian B McGavern; Michael B A Oldstone; Juan Carlos de la Torre
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan.

Authors:  Stefan Kunz; Jillian M Rojek; Mar Perez; Christina F Spiropoulou; Michael B A Oldstone
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 9.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

Review 10.  X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.

Authors:  Hamid Bassiri; W C Janice Yeo; Jennifer Rothman; Gary A Koretzky; Kim E Nichols
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.